Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction

AIMS: Murine models implicate phosphodiesterase 9A (PDE9A) as a nitric oxide‐independent regulator of cyclic guanosine monophosphate and promising novel therapeutic target in heart failure (HF) with preserved ejection fraction (HFpEF). This study describes PDE9A expression in endomyocardial biopsies...

Descripción completa

Detalles Bibliográficos
Autores principales: Besler, Christian, Rommel, Karl‐Philipp, Kresoja, Karl‐Patrik, Mörbitz, Justus, Kirsten, Holger, Scholz, Markus, Klingel, Karin, Thiery, Joachim, Burkhardt, Ralph, Büttner, Petra, Adams, Volker, Thiele, Holger, Lurz, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120363/
https://www.ncbi.nlm.nih.gov/pubmed/33787083
http://dx.doi.org/10.1002/ehf2.13327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120363/
https://www.ncbi.nlm.nih.gov/pubmed/33787083
http://dx.doi.org/10.1002/ehf2.13327

Ejemplares similares